Agilent Raises Outlook on Q3 Growth
Werte in diesem Artikel
Agilent Technologies(NYSE:A) reported Q3 FY2025 revenue of $1.74 billion, up 6.1% year-over-year on a core basis, with non-GAAP EPS of $1.37, both exceeding guidance. The company raised its full-year revenue outlook to $6.91 billion-$6.93 billion (core growth 4.5% at midpoint), despite higher tariff expenses, driven by robust demand in both Pharma and Chemicals & Advanced Materials. Key insights from the earnings call highlight multi-segment growth, margin pressures from tariffs and investment, and a strong innovation pipeline supporting future demand.Agilent achieved five consecutive quarters of accelerating core revenue growth through Q3 FY2025, with broad-based performance led by double-digit expansion in pharmaceutical and chemicals end markets. The Life Sciences and Diagnostics segment grew 7% core year-over-year, highlighted by mid-teens growth in the Infinity Tree LC platform and over 20% core revenue growth in the NASD contract development and manufacturing organization (CDMO) business.The company’s ability to accelerate growth across multiple segments and raise guidance, even amid external headwinds, demonstrates strong execution and positions Agilent to capitalize on secular demand trends in its core markets.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Übrigens: Agilent Technologies und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Agilent Technologies
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Agilent Technologies
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: MotleyFool
Nachrichten zu Agilent Technologies Inc.
Analysen zu Agilent Technologies Inc.
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2019 | Agilent Technologies Equal Weight | Barclays Capital | |
30.05.2019 | Agilent Technologies Peer Perform | Wolfe Research | |
25.02.2019 | Agilent Technologies Buy | Needham & Company, LLC | |
03.01.2019 | Agilent Technologies Buy | Needham & Company, LLC | |
21.11.2017 | Agilent Technologies Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
25.02.2019 | Agilent Technologies Buy | Needham & Company, LLC | |
03.01.2019 | Agilent Technologies Buy | Needham & Company, LLC | |
21.11.2017 | Agilent Technologies Overweight | Barclays Capital | |
18.01.2017 | Agilent Technologies Buy | Deutsche Bank AG | |
04.01.2017 | Agilent Technologies Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2019 | Agilent Technologies Equal Weight | Barclays Capital | |
30.05.2019 | Agilent Technologies Peer Perform | Wolfe Research | |
17.05.2016 | Agilent Technologies Equal Weight | Barclays Capital | |
07.01.2016 | Agilent Technologies Hold | Deutsche Bank AG | |
07.01.2016 | Agilent Technologies Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
06.02.2009 | Varian underweight | Barclays Capital | |
16.08.2005 | Agilent sell | Banc of America Sec. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Agilent Technologies Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen